RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.790
-0.050 (-5.98%)
At close: Mar 6, 2026, 4:00 PM EST
0.820
+0.030 (3.76%)
After-hours: Mar 6, 2026, 7:10 PM EST
RenovoRx Employees
RenovoRx had 10 employees as of December 31, 2024. The number of employees increased by 2 or 25.00% compared to the previous year.
Employees
10
Change (1Y)
2
Growth (1Y)
25.00%
Revenue / Employee
$92,800
Profits / Employee
-$1,110,500
Market Cap
28.96M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10 | 2 | 25.00% |
| Dec 31, 2023 | 8 | -1 | -11.11% |
| Dec 31, 2022 | 9 | 3 | 50.00% |
| Dec 31, 2021 | 6 | -3 | -33.33% |
| Dec 31, 2020 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Werewolf Therapeutics | 39 |
| Lantern Pharma | 24 |
| AN2 Therapeutics | 22 |
| Tempest Therapeutics | 21 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Rein Therapeutics | 11 |
RNXT News
- 7 days ago - RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - GlobeNewsWire
- 8 days ago - RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Radiology Annual Scientific Meeting - GlobeNewsWire
- 24 days ago - RenovoRx Establishes RenovoCath® Medical Advisory Board - GlobeNewsWire
- 4 weeks ago - RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer - GlobeNewsWire
- 4 weeks ago - RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting - GlobeNewsWire
- 5 weeks ago - RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting - GlobeNewsWire
- 6 weeks ago - RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center - GlobeNewsWire
- 7 weeks ago - RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026 - GlobeNewsWire